News from valeant pharmaceuticals international, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 02, 2013, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Medicis Announces Five-Year Aesthetic Collaboration with Mentor

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced that Valeant's Medicis division, a leader in facial...

Jun 27, 2013, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (the "Company") announced today that VPII Escrow Corp., a newly formed...

Jun 24, 2013, 09:22 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces Closing of Public Offering of Common Shares

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) reports the closing of its recently priced public offering (the "Offering")...

Jun 20, 2013, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces Exercise Of Over-Allotment Option

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) and (TSX: VRX) (the "Company") reports that the underwriters of its recently priced...

Jun 18, 2013, 22:21 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (the "Company") announced today that VPII Escrow Corp., a newly formed wholly...

Jun 18, 2013, 19:25 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Prices Public Offering Of Common Shares

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) has priced its previously announced public offering of common shares (the...

Jun 17, 2013, 16:02 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces Public Offering Of Common Shares

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has filed a preliminary prospectus supplement to its...

Jun 07, 2013, 14:28 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces Filing Of Preliminary Base Shelf Prospectus

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that it has filed a preliminary base shelf prospectus in...

May 28, 2013, 07:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it has received a Complete Response Letter (CRL)...

May 27, 2013, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals International, Inc. To Acquire Bausch + Lomb For $8.7 Billion

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Bausch + Lomb Holdings Incorporated, the global eye health company,...

May 21, 2013, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces 2013 Annual Meeting Results

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of ten directors nominated at its 2013 annual...

May 20, 2013, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a...

May 15, 2013, 20:15 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that Dr. Laurence Paul has resigned from Valeant's Board of...

May 13, 2013, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual...

May 10, 2013, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has provided additional information related to the...

May 02, 2013, 20:14 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Provides Efinconazole Update

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that we agreed this afternoon that the launch of efinaconazole, our...

May 02, 2013, 06:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results

-  2013 First Quarter Total Revenue $1.068 billion; an increase of 25% over the prior year -  2013 First Quarter Product...

May 01, 2013, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel

Actavis, Inc. (NYSE: ACT), and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Actavis Specialty Brands...

Apr 25, 2013, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the expiration of the tender offer (the...

Apr 24, 2013, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its Previously Announced Acquisition of Obagi Medical Products, Inc.

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced that it has received approval by the Antimonopoly Committee of...